Replimune Group, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q1 2017 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Replimune Group, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q1 2017 to Q1 2024.
  • Replimune Group, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending March 31, 2024 was $162M, a 42.1% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $162M +$48M +42.1% Mar 31, 2024 10-K 2024-05-16
Q1 2023 $114M +$39M +52.1% Mar 31, 2023 10-K 2024-05-16
Q1 2022 $74.9M +$34.9M +87.1% Mar 31, 2022 10-K 2024-05-16
Q1 2021 $40M +$22.7M +131% Mar 31, 2021 10-K 2023-05-18
Q1 2020 $17.3M +$7.93M +84.4% Mar 31, 2020 10-K 2022-05-19
Q1 2019 $9.4M +$4.67M +98.9% Mar 31, 2019 10-K 2021-05-20
Q1 2018 $4.72M +$2.84M +150% Mar 31, 2018 10-K 2020-06-03
Q1 2017 $1.89M Mar 31, 2017 10-K 2019-06-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.